M28 Capital Management LP Long-Term Concentrated

CIK: 0001807489 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 13, 2025

Total Value ($000): $58,627 (100.0% shares, 0.0% debt)

Holdings (9)

WVE WAVE LIFE SCIENCES LTD 62.8%

Value ($000) $36,820 Shares 5,664,548 Est. Cost $3.40 Unrealized +94.3%

IVVD INVIVYD INC 11.3%

Value ($000) $6,612 Shares 9,248,250 Est. Cost $17.64 Unrealized -96.0%

TGTX TG THERAPEUTICS INC 9.9%

Value ($000) $5,816 Shares 161,600 Est. Cost $15.49 Unrealized +140.3%

GUTS FRACTYL HEALTH INC 5.1%

Value ($000) $3,007 Shares 1,856,117 Est. Cost $8.42 Unrealized -80.8%

PRQR PROQR THRAPEUTICS N V 3.5%

Value ($000) $2,080 Shares 1,019,498 Est. Cost $2.38 Unrealized -31.6%

CRIS CURIS INC 2.1%

Value ($000) $1,209 Shares 521,059 Est. Cost $11.24 Unrealized -82.5%

SLN SILENCE THERAPEUTICS PLC 1.8%

Value ($000) $1,074 Shares 185,100 Est. Cost $9.41 Unrealized —

ARWR ARROWHEAD PHARMACEUTICALS IN 1.8%

Value ($000) $1,065 Shares 67,400 Est. Cost $33.13 Unrealized -56.7%

RCKT ROCKET PHARMACEUTICALS INC 1.6%

Value ($000) $945 Shares 385,680 Est. Cost $23.75 Unrealized -78.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
WVE	WAVE LIFE SCIENCES LTD	5,664,548	$36,820	62.8%	$3.40	+94.3%	SHS	Y95308105
IVVD	INVIVYD INC	9,248,250	$6,612	11.3%	$17.64	-96.0%	COM	00534A102
TGTX	TG THERAPEUTICS INC	161,600	$5,816	9.9%	$15.49	+140.3%	COM	88322Q108
GUTS	FRACTYL HEALTH INC	1,856,117	$3,007	5.1%	$8.42	-80.8%	COM	35168W103
PRQR	PROQR THRAPEUTICS N V	1,019,498	$2,080	3.5%	$2.38	-31.6%	SHS EURO	N71542109
CRIS	CURIS INC	521,059	$1,209	2.1%	$11.24	-82.5%	COM	231269309
SLN	SILENCE THERAPEUTICS PLC	185,100	$1,074	1.8%	$9.41	—	ADS	82686Q101
ARWR	ARROWHEAD PHARMACEUTICALS IN	67,400	$1,065	1.8%	$33.13	-56.7%	COM	04280A100
RCKT	ROCKET PHARMACEUTICALS INC	385,680	$945	1.6%	$23.75	-78.7%	COM	77313F106